|
---|
IL-1 | - Agonis: Interleukin 1 (α, β)
- Mobenakin
- Pifonakin
- Antagonis: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
- Antibodi: Sanakinumab
- Gevokizumab
- Lutikizumab
- Reseptor palsu: Rilonasep (perangkap IL-1)
|
---|
IL-2 | - Agonis: Adargileukin alfa
- Aldesleukin
- Selmoleukin
- Denileukin diftitoks
- Interleukin 2
- Pegaldesleukin
- Teseleukin
- Tukotuzumab selmoleukin
- Antibodi: Basiliksimab
- Daklizumab (dakliksimab)
- Inolimomab
|
---|
IL-3 | - Agonis: Daniplestim
- Interleukin 3
- Leridistim
- Milodistim
- Muplestim
- Promegapoietin
|
---|
IL-4 | - Agonis: Binetrakin
- Interleukin 4
- Interleukin 13
- Antibodi: Dupilumab
- Paskolizumab
|
---|
IL-5 | - Antibodi: Benralizumab
- Mepolizumab
- Reslizumab
- Oligonukleotida antideria: TPI ASM8
|
---|
IL-6 | - Agonis: Ateksakin alfa
- Interleukin 6
- Antibodi: ARGX-109
- Klazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuksimab
- Sirukumab
- Tosilizumab
- Levilimab
|
---|
IL-7 | |
---|
IL-8 | - Lihat CXCR1 (IL-8Rα) dan CXCR2 (IL-8Rβ) di sini.
|
---|
IL-9 | |
---|
IL-10 | |
---|
IL-11 | - Agonis: Interleukin 11 (AGIF)
- Oprelvekin
|
---|
IL-12 | - Agonis: Edodekin alfa
- Interleukin 12
- Antibodi: Briakinumab
- Ustekinumab
|
---|
IL-13 | - Agonis: Binetrakin
- Sintredekin besudotoks
- Interleukin 4
- Interleukin 13
- Antibodi: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
---|
IL-15 | - Agonis: ALT-803
- Interleukin 15
|
---|
IL-17 | - Agonis: Interleukin 17 (A, B, C, D, E (interleukin 25), F)
- Antibodi: Brodalumab
- Iksekizumab
- Perakizumab
- Remtolumab
- Sekukinumab
- Vunakizumab
|
---|
IL-18 | - Agonis: Iboktadekin
- Interleukin 18
- Interleukin 37
- Tadekinig
|
---|
IL-20 | - Agonis: Interleukin 19
- Interleukin 20
- Interleukin 24
- Antibodi: Fletikumab (melawan IL-20)
|
---|
IL-21 | - Agonis: Denenikokin
- Interleukin 21
- Antibodi: NNC0114-0005
- NNC0114-0006
|
---|
IL-22 | - Antibodi: Fezakinumab (melawan IL-22)
|
---|
IL-23 | - Agonis: Interleukin 23 (SGRF)
- Antibodi: Brazikumab
- Briakinumab
- Guselkumab
- Risankizumab
- Tildrakizumab
- Ustekinumab
|
---|
IL-27 | - Agonis: Interleukin 27 (interleukin 30)
|
---|
IL-28 | - Agonis: Interferon λ4 (IFN-λ4)
- Interleukin 28 (A (IFN-λ2), B (IFN-λ3))
- Interleukin-29 (IFN-λ1)
|
---|
IL-31 | |
---|
IL1RL1 | |
---|
IL1RL2 | - Agonis: Interleukin 36 (α, β, γ)
- Interleukin 38
|
---|
Lain-lain | JAK | |
---|
Lain-lain | - Interleukin 14 (taksilin alfa, HMW-BCGF)
- Interleukin 16 (berisyarat melalui CD4)
- Interleukin 24 (berisyarat melalui heterodimer IL-22Rα1/IL-20Rβ)
- Interleukin 26 (berisyarat melalui heterodimer IL-20Rα/IL-10Rβ)
- Interleukin 32
- Interleukin 34 (berisyarat melalui M-CSFR/CSF1R)
- Interleukin 35
- Tidak dikelaskan: Efavaleukin alfa
- Efineptakin alfa
|
---|
|
---|